Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test a new treatment of pancreatic cancer that cannot be
removed by surgery. This treatment is a Phase I dose escalation research study which will
combine one drug at increasing doses with a fixed dose of a second drug and radiation
therapy. The drug that will be used at increasing doses is gemcitabine whereas 5-fluorouracil
will remain the same for all patients.
Phase:
Phase 1
Details
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborators:
Brigham and Women's Hospital Massachusetts General Hospital